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Systematic reviews often encounter primary studies that report multiple effect sizes based on data 
from the same participants. These have the potential to introduce statistical dependency into the 
meta-analytic data set. In this paper we provide a tutorial on dealing with effect size multiplicity 
within studies in the context of meta-analyses of intervention and association studies, 
recommending a three-step approach. The first step is to define the research question and consider 
the extent to which it mainly reflects interest in mean effect sizes (which we term a ‘convergent’ 
approach) or an interest in exploring heterogeneity (which we term a ‘divergent’ approach). A 
second step is to identify the types of multiplicities that appear in the initial database of effect sizes 
relevant to the research question, and we propose a categorization scheme to differentiate them. 
The third step is to select a strategy for dealing with each type of multiplicity. The researcher can 
choose between a ‘reductionist’ meta-analytic approach, which is characterized by inclusion of a 
single effect size per study, or an ‘integrative’ approach characterized by inclusion of multiple effect 
sizes per study. We present an overview of available analysis strategies for dealing with effect size 
multiplicity within studies, and provide recommendations intended to help researchers decide which 
strategy might be preferable in particular situations. Last, we offer caveats and cautions about 
addressing the challenges multiplicity poses for systematic reviews and meta-analyses. 






Dealing with effect size multiplicity  
in systematic reviews and meta-analyses 
Systematic reviews often encounter primary studies that report multiple effect sizes.1, 2 For example, 
a study may have measured more than one outcome on each participant (e.g. depression and 
anxiety), may have used multiple measures of the same outcome (e.g. different depression scales), 
may have taken measurements at multiple time points (e.g. at 1 month and 6 months), and may 
report results for different subgroups with some degree of overlap (e.g. men, women, young adults 
and elderly adults). Such effect size multiplicity in primary studies may introduce statistical 
dependency into the meta-analytic data set.3 Specifically, if the same participants contribute to two 
or more effect sizes, then those effect sizes cannot be regarded as statistically independent and 
should not be treated as if they are in the meta-analysis.4 Ignoring statistical dependencies can lead 
to misleading results, as has been noted by various authors,5, 6 and demonstrated in simulation 
studies.7, 8 It is therefore important to deal with multiplicity in some appropriate way, and the 
decisions made can have a substantial impact on the results of the meta-analysis.9 
Here we focus on studies providing effect sizes that represent an association between two 
constructs. This includes intervention studies linking treatment conditions with subsequent 
outcomes, correlational studies linking two variables, and observational studies linking exposures 
with subsequent outcomes. We focus on studies that supply multiple effect sizes that are based (at 
least partially) on the same study participants.  Various situations in which multiple effect sizes of 
this sort may be reported (or can be computed) are described in Table 1, based on examples in the 
literature.4, 10 We also describe in the table how the multiplicity can lead to statistical dependencies 
across effect sizes from the same study. Multiplicity is only an issue for effect sizes that are relevant 
to the purpose of the review, and multiple effect sizes may be found either within a single report of 
a study or across multiple reports of the same study. 
TABLE 1 HERE 
There are several different ways to handle multiple statistically dependent effect sizes of these 
various sorts, and no single way is appropriate for all situations. In this tutorial we provide a 
roadmap to the strategies and options available and offer guidance for making appropriate choices. 
We propose that multiplicity be addressed in a sequence of three steps: (1) specify the research 
question and recognize its implications for multiplicity, (2) identify the nature and amount of 
multiplicity in the initial database of effect sizes relevant to the research question, and (3) choose an 
appropriate procedure for handling each kind of multiplicity identified. We provide 
recommendations intended to help researchers decide which strategy might be preferable in their 
particular situation. Finally, we summarize the messages of the paper through a suggested decision 
algorithm, and conclude with some caveats and cautions.  
We make the important remark at the outset that approaches for dealing with multiplicity should be 
pre-specified in the review protocol wherever possible. We also stress that processes are often 
iterative in practice, because researchers may need to revise assumptions made about which effect 
sizes should be combined, and how, in the light of the sources of multiplicity found in the primary 
studies.  
 
1. Defining the research question and setting eligibility criteria 
Decisions made in the early stages of a systematic review impact on the nature and extent of 
multiplicity in the collected data. A first step in any systematic review is to specify the research 




inform the inclusion and exclusion criteria for primary studies and determine which effect sizes are 
relevant to the purpose of the review. The scope of the research question and, correspondingly, of 
the eligible primary studies, will generally have considerable influence on the nature and number of 
multiple statistically dependent effect sizes the researcher will encounter. 
In relation to the broad synthesis plans, two ends of a continuum can be distinguished, which we will 
label as convergent and divergent review frameworks. Convergent reviews usually take a 
confirmatory approach. They focus on a rather narrowly circumscribed research question, typically 
an association previously hypothesized in the field that involves constructs and associated effect 
sizes expected to be relatively homogenous. A review of this sort is implemented through inclusion 
criteria that constrain studies to be relatively similar to each other with regard to the relationship 
examined and the way those relationships are represented empirically. The aim of convergent 
reviews is mainly to estimate an overall mean effect size, or a few mean effect sizes. Limited 
variability around those means is expected and, consequentially, there are few relevant moderator 
relationships to explore. Convergent frameworks are frequent in the health sciences, where 
inclusion criteria are typically more restrictive and the relevant constructs and measures are likely to 
be more tightly defined than in other disciplines.11 A prototypical example is a review of clinical trials 
of a particular treatment for patients with a particular condition that examines only the outcomes 
most important to patients.12 
In contrast, divergent frameworks tend to take an exploratory approach. They address a broad 
research question with a primary focus on identifying sources of variation among effect sizes that 
are expected to show substantial statistical heterogeneity such that interpretation of an overall 
mean effect size might be challenging, or even meaningless.13-15 Their inclusion criteria are typically 
broad and may involve a range of diverse constructs and relationships. A divergent framework may 
help generate new hypotheses through a wider examination of moderators than can be achieved in 
primary studies. This is particularly useful for reviews dealing with complex constructs such as 
multifaceted interventions, where many factors may affect the magnitude of the association 
between the two constructs of interest. Divergent frameworks are not unusual in the social and 
behavioural sciences.  Prototypical examples are reviews of the differential strength of a range of 
predictors of an outcome of interest,16 or the relative effectiveness of different treatment modalities 
within a broad family under different conditions.17 
A comparison of convergent and divergent review frameworks is provided in Table 2. In practice, 
most systematic reviews will fall somewhere between the two extremes. Effect size multiplicity 
within studies will be more common among reviews on the divergent side. Furthermore, reviews 
within the convergent framework will often be characterized by inclusion of a smaller number of 
studies and effect sizes per study.  
TABLE 2 HERE 
As an example, consider the planning of a systematic review and meta-analysis to examine the 
effectiveness of cognitive-behavioural therapies (CBT) in adults with anxiety disorder. A highly 
convergent approach to such a review might target the specific comparison of individually 
administered CBT versus no CBT, focussing on its effects on depression as measured using the Beck’s 
Depression Inventory (BDI) and requiring use of an intention-to-treat (ITT) analysis. At the other 
extreme, a highly divergent approach might instead allow any comparison of a variant of CBT against 
something different and any analysis of any outcome. In later sections we develop this example with 
reference to a published systematic review on the topic.18  We would classify this as predominantly a 
divergent review because the authors’ scope was broad and embraced studies examining 
participants with different psychiatric disorders treated with a wide range of psychological 




included (both anxiety and depression), and different analysis approaches were entertained (both 
ITT analysis and analysis of completers only).  
 
2. Examining the effect sizes in the database 
The specification of the research question and the associated study inclusion criteria provide the 
basis for identifying eligible studies and eligible effect sizes. At this point, the choice of effect sizes to 
extract becomes important. It may not be appropriate to extract some types of effect sizes that 
could create multiplicity, either because they are not relevant to the research question or because it 
is known that they are too infrequent to support analysis even if extracted. For example, effect sizes 
for specific subgroups of the total sample, or for specific outcomes, might not be extracted for such 
reasons.  
Once the relevant effect sizes have been extracted, it is time to think about the extent to which 
these can be combined in a meta-analysis, a notion we refer to as combinability. A first consideration 
is the statistical combinability of effect sizes. Effect sizes using very different metrics (e.g. a 
difference in means and a ratio of means) cannot be combined directly with each other in a meta-
analysis. Sometimes conversions can be made between effect metrics, such as among standardized 
mean differences, odds ratios and correlation coefficients, although these conversions rest on 
assumptions that need to be considered. Sometimes effect metrics can be regarded as similar 
enough to be combined (e.g. odds ratios, rate ratios and risk ratios when the event is rare; or 
regression coefficients from analyses that adjust for different sets of confounders). Decisions about 
what effect sizes are in principle combinable may reduce the amount of multiplicity in any individual 
synthesis. Note, however, that some meta-analytic techniques, such as multivariate meta-analysis, 
allow for different metrics to be combined legitimately in a single analysis.  
A second consideration is around which effect sizes are sensible to combine, taking into account 
substantive rather than statistical issues. The research questions for the review are fundamental to 
decisions made in this regard, and issues of combinability for a convergent approach to the review 
are likely to be different from those for a divergent approach. Within any set of studies deemed 
combinable according to a particular research question, the sources of multiplicity listed in Table 1 
should be considered.  
Sources of multiplicity in a systematic review of CBT interventions in adults with different anxiety 
disorders are summarized in Table 3.18 A highly convergent approach to the review (or to a particular 
meta-analysis within the review) might target the specific comparison of individual CBT versus 
placebo using ITT analyses of BDI scores. In this case there is no effect size multiplicity, since none of 
the studies in this example provides more than one result relevant to this question. However, there 
are only two studies that meet these narrow criteria, illustrating the limitations of asking such a 
specific question. For the most highly divergent approach, all effect sizes in the data set are relevant, 
so there is substantial multiplicity with 115 effect sizes arising from the 26 studies. Within each 
study, the multiple effect sizes are derived wholly or in part from the same individual participants 
and thus all are statistically dependent. 
Note that the extent of multiplicity in this example varies by different aspects of the research 
question. For intervention comparisons there is minimal multiplicity: only one study (study 24) 
contributes more than one comparison. For outcomes, there is similar multiplicity in all studies in 
that most of them report effect sizes for anxiety and for depression. The extent of multiplicity is 
largest for outcome measures, since several studies used multiple scales to measure depression or 
anxiety. For the analysis approach, multiplicity arises in five studies presenting both ITT and 




TABLE 3 HERE 
Tables of study characteristics are useful to visualize the extent and structure of the multiplicities in 
the review database. It is a generally good practice to construct a table detailing each included study 
to report in every systematic review.19 Selecting a format that displays sources of multiplicity, such 
as Table 3 above, may help identify the sources that are common enough to pose a methodological 
challenge. Alternative formats, such as tables or matrices that explicitly quantify the extent of one or 
more types of multiplicity in terms of number of studies and effect sizes, are also possible. 
 
3. Deciding on an analysis strategy 
After the characteristics of the effect sizes in the database have been thoroughly examined, the third 
step is to proceed with the meta-analysis. Although pre-specified analysis plans should be followed 
wherever possible, the frequency and nature of multiplicity can be difficult to predict, so the plans 
will often need to be refined. At one extreme, very few effect sizes may meet the predefined criteria 
and a broader question might then become the focus of the synthesis. More challenging problems of 
multiplicity arise at the other extreme, when there are many eligible effect sizes from each study. At 
this point it may become apparent that the most insight will be gained by combining multiple effect 
sizes per study in a single synthesis (therefore introducing a need to account for statistical 
dependencies), by performing multiple syntheses when only one was planned, or by undertaking 
extra statistical investigations of heterogeneity in effect sizes within (and possibly across) studies.  
We distinguish between two general approaches to dealing with effect size multiplicity within 
studies in a meta-analysis, which we call the reductionist approach and the integrative approach. 
The reductionist approach seeks to reduce the data set to minimal representations of the 
relationships of interest before performing the meta-analysis. This typically leads to one effect size 
from each independent study being included in each meta-analysis so that dependencies do not 
need to be modelled. However, there may be some loss of precision in the results if this appreciably 
reduces the total number of effect sizes included in the analysis.  
In contrast, the integrative approach includes multiple effect sizes from each study in a single meta-
analysis. This may be either because the effect sizes within the same study are considered to be 
equivalent but informative, or because the effect sizes differ in ways that can potentially be 
accounted for by moderators. This approach may lead to gains in statistical precision in the meta-
analysis, but will introduce statistical dependencies that need to be modelled or accounted for in the 
statistical analysis to avoid misleading results. A comparison of the reductionist and integrative 
approaches is presented in Table 4. 
TABLE 4 HERE 
The reductionist and integrative approaches are not mutually exclusive. The effect sizes in a given 
meta-analytic database may include instances of more than one of the types of multiplicity 
distinguished in Table 1. Depending on the nature of the multiplicity and the purposes of the meta-
analysis, some of those might be handled with reductionist strategies while others are handled with 
integrative strategies. 
Returning to the running example of CBT for anxiety disorders, consider first the multiplicity posed 
by the intervention comparisons being made, in which only one study introduced an issue by 
comparing three interventions. Simple approaches might be taken for this source of multiplicity, 
such as omitting the extra effect size. For outcomes, the availability of data for anxiety and for 
depression from most studies opens up the possibility of using multivariate meta-analysis to analyse 




multiplicity. The actual measurement instruments for anxiety suggest that some of them might be 
comparable (e.g. different versions of the same scale, different anxiety inventories), whereas others 
could be measuring symptoms pertaining to different anxiety disorders (e.g. social phobia, 
obsessive-compulsive disorder, social anxiety, panic disorder). For this area of multiplicity, it would 
be important to take a careful approach, for example either by selecting specific scales or by 
accounting for statistical dependencies. For the multiplicity posed by ITT and completer analysis 
approaches, it is likely to be most reasonable to select the preferred approach over the less 
preferred approach, or to undertake separate analyses, rather than to account for the statistical 
dependencies between the two analyses.  
In fact, the authors of the review performed separate meta-analyses for anxiety and depression, and 
separate analyses for ITT and completer approaches. They lumped all intervention comparisons into 
a single category (CBT vs. control), dropping one relevant comparison from study 24 and exploring 
the association between the specific intervention and comparator types and the effect sizes through 
moderator analyses at a later stage (an alternative analysis approach here is network meta-analysis, 
see Section 5). The authors averaged the effect sizes over multiple measurement instruments. We 
would characterize this as reductionist meta-analysis.  
Reductionist approaches address multiplicity by resolving it within studies, thereby removing it from 
the meta-analysis. Clearly this limits the possibility of exploring sources of heterogeneity within 
studies. In contrast, integrative approaches allow within-study effect size differences to be explored 
but introduce statistical issues with regard to the dependent effect sizes. In the following two 
sections we review the main strategies within the reductionist and integrative approaches, 
respectively. 
 
4. Strategies to obtain non-dependent effect sizes  
4.1 Random selection. Some multiple effect sizes from the same study sample may be regarded as 
completely equivalent conceptually for the purpose of the meta-analysis. For example, there may be 
different ways of measuring an outcome construct that the meta-analyst views as equally valid and 
relevant to the research question. One straightforward way to deal with multiplicity of this sort is to 
select one effect size randomly from each set of such effect sizes. Effect sizes that are truly 
equivalent should yield essentially the same results from the statistical analysis irrespective of which 
is selected from the respective sets of multiple effect sizes (after accounting for the metric and 
providing the study is large enough to have sufficient precision). However, equivalence of effect 
sizes from the same study is a strong assumption that may not be realistic, and the meta-analysis 
results may differ in ways that matter depending on which effect sizes are chosen.9 If there are many 
instances of multiple effect sizes handled this way, sensitivity analyses comparing the results with 
different random draws may be appropriate to test the assumption of equivalence. Also, if there are 
many such instances, a drawback of this approach is loss of information associated with the omitted 
effect sizes and the associated loss of statistical precision and statistical power stemming from the 
smaller number of effect sizes contributing to the analysis.  
4.2 Averaging effect sizes. Another simple way to reduce multiple effect sizes within a study to a 
single independent effect size is to average them. Especially for systematic reviews aimed mainly at 
estimating the overall mean effect size, averaging multiple effect sizes within studies before 
averaging them across studies has a straightforward logic. Possibilities include computation of the 
arithmetic mean or the median values, although more sophisticated procedures are available20, 21 
and the choice may influence the results.22 One advantage of the arithmetic mean is that its 




Borenstein and colleagues.23 However, these formulae require the correlations between the 
variables whose effect sizes are being averaged (e.g. different outcome variables in an intervention 
study). Such information is often not reported in the primary studies24 and typically cannot be 
computed directly without individual participant data. In practice the correlations would often need 
to be imputed.  
Averaging effect sizes is a simple and arguably objective strategy that makes use of all the relevant 
effect sizes. Its limitation is that it ignores any within-study variability across the effect sizes 
combined in those averages. Also, as we have noted, the correct standard error of a within-study 
averaged effect will depend on the correlation structure of the summarized variables, which is rarely 
available. One alternative is to average the variances of the effect estimates and use that value as 
the variance of the averaged effect size. This approach does not convey the increased precision that 
comes with having more effect size estimates, although that might be considered a positive feature 
because it does not award greater influence to studies that provide multiple effect sizes relative to 
those that provide only one. 
4.3 Selection using a decision rule. A third option to obtain non-dependent effect sizes is to select a 
single most relevant effect size from each source of within-study multiplicity according to a decision 
rule. This strategy attempts to maximize the comparability of the effect sizes across studies while 
still restricting the meta-analysis to one effect size per study sample. Decision rules may be 
especially appropriate when multiple effect sizes within studies are regarded as being loosely 
equivalent but not completely interchangeable, and when the effect size diversity within studies is 
not very similar to that between studies. With effect sizes involving measures of depression, for 
example, most studies might use the BDI, but some might also include a second depression measure. 
The selection rule in that case might be to choose the BDI in preference to other depression scales if 
it is available. Similarly, a decision rule might specify effect sizes based on ITT analyses in preference 
to completer analyses, or to prioritize adjusted regression coefficients in preference to unadjusted 
ones, or to choose the longest period of follow up.  
When such decision rules are to be used, both Cochrane and the Campbell Collaboration consider it 
desirable that specification of the rule be done before data extraction. However, a recent survey of 
systematic reviews suggested that this recommendation is rarely followed in practice.1 Pre-
specification can be challenging when insufficient information is available in advance to predict the 
nature of the multiplicity, and therefore what kind of decisions will be needed. As stated in the 
Cochrane Handbook for Systematic Reviews of Interventions,25 the rationale for specifying a decision 
rule before data extraction is to minimize bias, and other organizations also recommend that such 
decision rules be used.26-29 If not prespecified, articulating decision rules as a post hoc strategy may 
still be appropriate if they are developed in a way that does not systematically select effect sizes 
based on their magnitude or direction.26  
Table 5 provides some suggestions for decision rules that select a single effect size per study for each 
source of multiplicity. We recommend that similar criteria be stated at the protocol stage if a 
decision rule is deemed appropriate for the review. An additional task for the review team will be to 
determine the order in which the different rules across domains should be applied, and the resulting 
decision rule might then look like a hierarchical algorithm. 
TABLE 5 
An example of a particularly detailed algorithm is provided by a review on the unintended effects of 
three childhood vaccines.30 The reviewers extracted 854 different effect sizes relating to 64 unique 




algorithm that was developed to reduce these effect sizes to one per study in order to overcome 
issues of multiplicity. 
BOX 1 HERE 
 
5. Modelling or accounting for dependency in the meta-analysis 
In this section, we describe several meta-analytic strategies available to researchers when the meta-
analytic data set includes dependency structures among effect sizes from the same participant 
samples. One option, not explicitly covered, is to ignore those dependencies and analyse the effect 
sizes as if they were all statistically independent. This approach will produce erroneous standard 
errors that will distort all the inferential statistics from the meta-analysis. While the consequences of 
this may be trivial if it involves only relatively few effect sizes in the data set,5 we generally 
discourage this naïve approach.  
5.1 Multivariate meta-analysis. A multivariate meta-analysis31, 32 provides meta-analytic estimates 
for all effect sizes of interest, including those that are statistically dependent, within a single 
modelling framework, even if different effect size metrics are present in the data set. This is 
achieved by integrating a covariance matrix into the analysis that carries information about the 
extent to which any two effect sizes are correlated. Using multivariate techniques to integrate effect 
sizes on different outcomes measured on the same participants is particularly attractive, as these 
models provide separate estimates for each outcome that are more precise than those from 
separate meta-analyses of each outcome. For example, a multivariate meta-analysis may be used to 
produce summary effect sizes for mathematics test scores separately from language test scores 
while accounting for the correlation between these scores when measured on the same children. 
Moreover, fitting a single model to obtain overall effect size estimates across outcomes avoids the 
inflation of the Type I error rate that might arise if separate meta-analyses were conducted for each 
of these outcomes.4, 10, 33, 34 
Multivariate meta-analysis has been recommended and shown to improve the performance of 
univariate meta-analysis in the presence of outcome reporting bias.35 This is achieved by ‘borrowing 
strength’ across correlated outcomes so that the magnitude and direction of the missing effect sizes 
can be estimated even if some outcomes are only partially reported across studies. Another 
common application of multivariate meta-analysis is to examine multiple intervention comparisons 
against a common control group, an approach known as network meta-analysis.36 A novel 
implementation of network meta-analysis allows mapping of effects from one outcome measure to 
another, providing an attractive alternative to the commonly used standardized differences in 
means as a dimensionless measure of effect.37  
Although multivariate meta-analysis is an elegant and powerful approach to handling multiple 
dependent effect sizes, its implementation requires information about the correlations between the 
effect sizes estimated from the same study samples (in the form of covariance matrices). This 
correlational information is rarely reported in source studies, which substantially limits the 
applicability of these methods in practice. Some strategies have been proposed to address this 
problem, both within a frequentist38 and a Bayesian39 framework. Software tools to implement 
multivariate meta-analysis include the mvmeta function in Stata40 and the metafor package in R.41 
5.2 Multilevel models. Another meta-analytic strategy to handling multiplicity is to use multilevel 
models, also known as hierarchical or mixed models.42, 43 A simple weighted average approach to 
meta-analysis can be conceived as a two-level hierarchical model as illustrated in Figure 1A. Here it is 




single estimate of that effect size based on data derived from its participant sample. The variability 
at the higher level, representing variation in the true effect sizes across studies, is commonly either 
modelled by assuming a distribution (as in random-effects meta-analysis) or assumed to be zero (as 
in a fixed-effect meta-analysis). The variability at the lower level, which reflects variation across 
participants within studies, is represented by within-study variances that are typically assumed to be 
measured without error. Effect size multiplicity within studies can be accounted for by introducing 
an intermediate level to the hierarchy, as displayed in Figure 1B for multiple measures of the same 
outcome. Additional complexity can be built in as needed to reflect the structure of the data, leading 
to models with more than three levels. An example is shown in Figure 1C, where a four-level model 
represents the combination of multiple time points and multiple measurement instruments within 
the studies. 
FIGURE 1 HERE 
The three-level model has been found to perform similarly to multivariate meta-analysis in terms of 
accuracy of parameter and standard error estimates,7 and has the advantage of being applicable in 
situations in which estimates of the covariances among effect sizes are not available, which are very 
common in practice. Multilevel models can be implemented in R, using the metaSEM44 or the 
metafor41 packages, and in SAS (Proc Mixed; some code is provided in Van den Noortgate and 
colleagues8).  
When synthesizing correlation matrices, an increasingly popular application of multilevel models is 
meta-analytic structural equation modelling (MASEM), bearing in mind the close link between 
multilevel modelling and structural equation modelling (SEM).45 In addition to the statistical 
integration of the correlation matrices reported in the primary studies, a second stage in MASEM 
typically involves testing models within a SEM framework.2, 46. While Mplus and LISREL are software 
choices familiar to SEM analysts, a more generic software option tailored to meta-analysis is the 
metaSEM package in R44, for which a tutorial has recently been published.47  
5.3 Robust variance estimation. The primary problem created by multiple statistically dependent 
effect sizes is distortion of the sampling variance estimates on which the inferential statistics for the 
meta-analysis are based. One approach to this problem is the use of robust variance estimation 
techniques that, as the name indicates, are robust to distortions. This strategy, developed by Hedges 
and colleagues48 and building on the work of Huber49 and White,50 has the advantage of 
simultaneously addressing all the different types of multiplicity that might appear in a meta-analytic 
data set with a single blanket procedure. It requires an estimate of the correlations across the effect 
sizes involved in instances of multiplicity, but the results are not very sensitive to a range of plausible 
estimates.  
As with most statistical methods used in meta-analysis, robust variance estimation relies on large-
sample approximations, and therefore estimates and statistical tests may yield inaccurate results 
when the number of studies and effect sizes is relatively small. To overcome this limitation, Tipton51, 
52 explored the performance of several small-sample corrections of the standard errors of the 
parameters in the meta-analytic model and of the degrees of freedom of the t-test on which 
statistical significance and confidence intervals were based. In her simulation study exploring the 
performance of these variants, some combinations of both adjustments were found to improve the 
performance of the statistical tests under a wide range of realistic scenarios. Robust variance 
estimation (with or without these small-sample corrections) can be implemented in R (using the 
robumeta or clubSandwich packages) or using macros developed for SPSS and Stata (for a tutorial, 




5.4 Specific methods for multiplicity in exposures or interventions. Some specific techniques are 
available to address multiplicity of interventions and exposures. A dose-response analysis allows 
multiple levels of exposures to be modelled explicitly. Care is required to model statistical 
dependencies if comparisons are used against a common reference category. An advantage of this 
approach is that dose-response relationships can be modelled both within and across studies.54 For 
multiple interventions, an important candidate is network meta-analysis, based on a connected 
network of within-study comparisons (the lines in a network diagram) from among a defined set of 
interventions (the nodes in a network diagram). 
 
6. A suggested approach to addressing multiplicity 
We provide a summary of the guidance offered in this paper in Figures 2 and 3. Figure 2 describes 
the three steps of a systematic review with which multiplicity can be addressed. The first step is to 
articulate the review question, specifying definitions of the constructs involved in the relationship(s) 
of interest, and clarifying the extent to which the review takes a convergent approach (in which 
narrow eligibility criteria are adopted to answer a highly focused question) or a divergent approach 
(in which wider eligibility criteria are used to bring diversity of effect sizes into the review).  
The second step is to examine the collected effect sizes for their combinability. This step includes 
both statistical and non-statistical considerations. Effect sizes measured using different metrics 
should not be combined statistically (unless multivariate meta-analysis is used), whereas effect sizes 
using the same metric may be considered as statistically combinable. Sensible decisions about which 
effect sizes should be combined involve standard considerations of the similarity of studies, and 
avoiding meta-analysis is a legitimate option if the effect sizes are not regarded as similar enough to 
be synthesized quantitatively. For effect sizes deemed reasonable to combine in a meta-analysis, 
sources of multiplicity need to be identified, according to the sources listed in Table 1. Tables are 
helpful to visualize the extent and structure of the multiplicities found in the included studies with 
regard to each particular proposed meta-analysis.  
The third step consists of choosing an analysis strategy to handle any multiplicity. Effect size 
multiplicity within studies may arise from multiple answers to the same research question or may be 
due to different questions being asked, such as effects on different comparisons or different 
outcome measures. A key decision is whether to perform separate meta-analyses to address the 
multiple research questions or whether to ‘lump’ the effect sizes into a single synthesis of a broader 
research question. Performing multiple separate meta-analyses might lead to inflated Type I error 
rates. Adjustments for multiple testing are available to address this problem, although they often 
yield over-conservative results and are not common in systematic reviews.25 Within a ‘lumped’ 
synthesis, meta-regression approaches enable examination of one or more moderators, controlling 
Type I error.55 They can be used to investigate between-study moderators (e.g. design 
characteristics) or within-study moderators (e.g. different outcome measures), or both.  
FIGURE 2 HERE 
Once a decision had been made to perform a meta-analysis (either a lumped analysis or one from a 
series of separate analyses), we propose the algorithm in Figure 3 to tackle each type of multiplicity. 
In the running CBT example (Table 3), there were four sources of multiplicity: intervention 
comparisons, outcomes (depression and anxiety), outcome measures (different scales) and analysis 
approaches (ITT vs. completers), and different strategies were used to address each of these. 
A starting point is whether the effect sizes within studies are completely interchangeable (or 




they are not expected to differ in relation to any moderators of interest. If this is the case, then 
averaging multiple effect sizes within studies is an especially straightforward way to handle 
multiplicity. However, if the extent of multiplicity is large, this strategy will discard potentially 
relevant information, resulting in loss of precision and statistical power in the model estimation, so 
that alternative strategies including all effect sizes and accounting for the statistical dependencies 
would be preferred. Among these, multilevel models and robust variance estimation are applicable 
in most situations, although the latter strategy (using small-sample corrections) will provide the best 
performance in terms of Type I error rate for the statistical tests with a small number of studies.56 
If the effect sizes within each study are not considered to be equivalent, then we might ask whether 
they differ in ways that are of interest (i.e. have different values in relation to moderator variables) 
or whether they differ more as nuisance variation. Moderator analyses may be pursued in the 
former case, but in the latter case the synthesis will need to address the diversity in other ways. This 
is the situation in which a decision rule may be particularly useful, so that the most appropriate 
effect size is selected for a meta-analysis. If a hierarchy cannot be specified, or there is a desire to 
include as many effect sizes as possible in the meta-analysis, then we suggest several options in 
Figure 3. 
FIGURE 3 HERE 
 
7. Conclusion 
Effect size multiplicity is a common challenge in systematic reviews because primary studies 
frequently report several effect sizes with at least partial overlap between samples of participants. 
We have offered recommendations to delimit, identify, and address such multiplicity in systematic 
reviews and meta-analyses. We provide an overview of different analysis strategies to deal with such 
multiplicity along with strengths and limitations of each alternative.  
In general, approaches for dealing with multiplicity should be specified in advance in a review 
protocol, including strategies for dealing with populations of interest, key constructs of interest 
(such as exposures, interventions, outcomes and measures of outcomes), follow-up times, and 
analysis approaches. In practice, however, it is difficult to anticipate all issues of multiplicity that may 
arise, and transparent reporting of decisions made is critical.  
Systematic reviews organized around convergent research questions will generally encounter few 
instances of effect size multiplicity. Furthermore, the types of multiplicity that may occur (Table 1) 
will often be predictable enough for some of them to be resolved in advance through the inclusion 
criteria. By contrast, divergent research questions will almost inevitably lead to systematic reviews 
that present many instances of multiplicity, often of quite diverse kinds. Nonetheless, many of the 
multiple dependent effect sizes may represent variation that is relevant to the purposes of the meta-
analysis given its focus on sources of variation in the observed effects.57 And, even if that were not 
the case, the number of multiple dependent effect sizes relevant to the research question will often 
be too large to be ignored and sufficiently large so that different choices about how to handle them 
could impact on the results of the meta-analysis. Careful planning for dealing with multiplicity and 
consideration of the implications of different choices are thus particularly important for meta-
analyses of broad scope that address divergent research questions. 
An examination of the database of effect sizes, as we suggest in Section 2, can lead to some 
immediate reductions in the extent of multiplicity. Some decisions made at this step may lead to 
data sets for separate meta-analyses. However, substantial multiplicity might still remain after this 




to reduce the data set to one effect size per study sample by implementing one or more of the 
strategies described in Section 4, which results in loss of information and statistical power. 
Alternatively, analysis strategies in Section 5 allow combination of all effect sizes while accounting 
for dependency structures, but this might raise issues of disproportionate influence on the meta-
analysis results from studies that contribute a large number of effect sizes relative to those that 
contribute fewer. 
We acknowledge that practical systematic reviews and meta-analyses may entail more complex 
scenarios than those we have addressed, for example because available information (e.g. within-
study correlation, number of studies) limits implementation of some strategies. A combination of 
different strategies, or even approaches, might sometimes be the best solution. We have focussed 
on reviews of association between two constructs, although most of the principles we outline apply 
to other types of studies. In spite of the challenges that it poses, effect size multiplicity provides 
exciting opportunities to explore different hypotheses in systematic reviews. 
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Table 1. Sources of effect size multiplicity in primary studies and how they might lead to statistical 
dependencies 
Source Examples Potential for dependency 
Populations/ groups (1) Investigators report effect sizes 
based on different overlapping 
subsets of participants, such as 
men only and older adults only. 
(2) Investigators report effect sizes 
for the whole sample and also for 
subpopulations. 
If separate effect sizes are reported 
based on (a) men only, (b) women 
only, (c) young adults, and (d) older 
adults, then all four effects should 
not be included in a meta-analysis 
assuming independent effect sizes 
because (a) and (b) include both 
younger and older adults, and (c) 
and (d) include both men and 
women. 






(1) An intervention study includes 
more than two arms, such as drug 
A, drug B, placebo, and thus allows 
for effect sizes from multiple 
comparisons (e.g. each drug versus 
drug placebo). 
Researcher is interested in the 
effect of either drug, compared with 
placebo, but inclusion of drug A 
versus placebo and drug B versus 
placebo comparisons in the meta-
analysis will double-count the 
placebo group. 
2. Outcomes or 
dependent 
variables 
More than one dependent variable 
is measured, such as panic, anxiety 
and depression, allowing 
examination of different outcomes. 
Researcher is interested in the 
effect of an intervention on mental 
health symptoms generally, so all 
three domains are relevant to the 
meta-analysis, but may be 




A correlational study looking at 
factors associated with educational 
achievement tested different 
variables (e.g. scores on several 
tests focused on different cognitive 
skills). 
Researcher is interested in a 
comprehensive set of factors 
associated with educational 
achievement, and hence all 
explored associations are relevant 
to the meta-analysis, but may be 
measured using the same 
participants. 
Ways of measuring 
the same construct  
A construct is measured in more 
than one way, such as with 
different self-reported measures, 
or a combination of self-reported 
measures with external assessment 
measures (e.g. clinical interviews) 
and objective measures (e.g. 
biological samples). A special case 
here is part-whole relations among 
measures (e.g. the total score on a 
scale as well as the scores on the 
subscales that are included in that 
total score are reported). 
All measures may be relevant to a 
particular meta-analysis, but they 





Time points An outcome domain or association 
is measured at different follow-up 
times. 
All time points may be of interest to 
a particular meta-analysis, but they 
include the same participants. 
Analyses (1) Investigators estimate the 
effect of an exposure factor using 
different effect size indices (e.g. 
risk ratio and risk difference), or 
report analyses both unadjusted 
and adjusted for confounders  
(2) Investigators estimate the 
magnitude of an association using 
total and partial correlations, or 
product-moment and rank 
correlation coefficients. 
(3) Investigators report results 
based on the intention-to-treat 
principle and also results including 
study completers only. 
(4) Different investigators report 
secondary analyses of data drawn 
from the same common database. 
All analyses may be relevant to a 
particular meta-analysis, but there is 
partial or complete overlap of 







Table 2. A comparison of convergent and divergent review frameworks 
Convergent Divergent 
Characterized by 
• Confirmatory approach 
• Single primary research question 
• Aims to include studies and effect sizes 
addressing the same (or a very similar) 
question 
• Focus on overall effect 
 
Implementation 
• Potential exclusion of informative data 
• Useful if the main goal is to quantify the 
association between the two constructs 
• Dominant in health sciences 
 
Characterized by 
• Exploratory approach 
• May involve multiple research questions 
• Aims to include diverse studies and effect 
sizes in the research area 
• Focus on variation 
 
Implementation 
• Often leads to large databases 
• Useful to generate new hypotheses 







Table 3. Table of study characteristics illustrating instances of multiplicity in a review of cognitive-
behavioural therapies for anxiety disorders (modified from Hofman and colleagues18) 
Study Intervention comparisons eligible 
for the systematic review 
Outcomes reported 







1 CBT vs. Supportive counseling Anxiety (1) 
Depression (1*) 
Completer 2 
2 CBT vs. Supportive counseling Anxiety (1) 
Depression (1*) 
Completer 2 
3 CBT vs. Supportive counseling Anxiety (1) 
Depression (1*) 
Completer 2 





5 CBT vs. Nondirective therapy Anxiety (5) 
Depression (2*) 
Completer 7 
6 CBT vs. Discussion group Anxiety (4) 
Depression (2*) 
Completer 6 
7 ERP vs. Placebo pill Anxiety (2) Completer 2 
8 BT vs. Systematic relaxation Anxiety (2) 
Depression (1) 
Completer 3 
9 ERP vs. Anxiety management Anxiety (3) 
Depression (1*) 
Completer 4 















13 CBT vs. Nondirective supportive 
therapy 
Anxiety (4) Completer 4 
14 CBT vs. Placebo pill Depression (1) ITT 1 
15 CBT vs. Supportive counseling Anxiety (5) 
Depression (1*) 
Completer 6 
16 CBT vs. Supportive counseling Anxiety (3) 
Depression (1*) 
Completer 4 
17 PE vs. Supportive counseling Anxiety (1) 
Depression (1*) 
Completer 2 
18 CBT vs. Relaxation Anxiety (2) 
Depression (1*) 
Completer 3 





20 NET vs. Supportive counseling Anxiety (2) Completer 2 
21 CT vs. Placebo pill Anxiety (7) 
Depression (1*) 
Completer 8 
22 CBT vs. Supportive therapy Anxiety (3) 
Depression (1*) 
Completer 4 
23 CCBT vs. Placebo pill Anxiety (3) Unclear 3 
24 CBGT vs. Educational group 
supportive therapy 













26 BT vs. Psychological Placebo Anxiety (1) Completer 1 
BT = Behaviour therapy; CBGT = Cognitive-behavioural group therapy; CBT = Cognitive-behavioural therapy; 
CCBT = Comprehensive cognitive-behavioural therapy; CT = Cognitive Therapy; ERP = Exposure and response 
prevention; ITT = Intention-to-treat analysis; NET = Narrative exposure therapy; PE = Prolonged exposure 





Table 4. Meta-analytic approaches to multiplicity 
Reductionist Integrative 
Characterized by 




• Estimation accuracy and statistical 
power may be diminished 
• Effect sizes included in each meta-
analysis are statistically independent 
Characterized by 
• Inclusion of multiple effect sizes from all or some 
studies in a meta-analysis 
 
Implementation 
• May lead to large meta-analytic data sets 
• Gain in statistical power 






Table 5. Considerations for selecting a single effect size per study 
Source of Multiplicity Suggestion 
Populations/ groups Select the effect size calculated based on the broadest 
population or the largest sample size. Note that it is often 
possible to use the data reported for subgroups to estimate the 
effect size for an aggregate that reassembles the full sample 
(e.g. combining the male and female subgroup data 
appropriately to get the effect size for the full sample even 
though the full sample results may not have been reported). 
Note that separate meta-analyses can be conducted for 
subgroups if those are reported widely enough across studies, 
(e.g. male and female subsamples). 
Constructs to be compared  
1. Interventions or exposure 
groups 
Select the intervention(s) or exposure(s) most relevant (e.g. 
interventions recommended for practice, most used, most 
fully-developed, or most implementable; or contrast using the 
largest sample sizes). Note that it is often possible to collapse 
data across intervention or exposure groups, if the 
interventions are sufficiently similar, to estimate a single effect 
size for a study. 
2. Outcomes or dependent 
variables 
Select the outcome most relevant (e.g. most familiar to 
readers, most frequently measured in practice). A practical 
strategy is to select the outcome or dependent variable for 
which the most studies contribute a result; the impact of 
reporting biases may need to be considered if such a strategy is 
used. It may be preferable to perform separate meta-analyses 
for each outcome or dependent variable if possible.  
3. Variables being correlated 
with each other 
Select the variables most relevant on a substantive basis (e.g. 
based on theoretical reasons, not numerical results). 
Ways of measuring the same 
construct 
Select operationalization with evidence of highest validity and 
reliability (e.g. objective measure); if different measures are 
believed to be equally valid, consider the most commonly used.  
Time points Select the time point most relevant or perhaps those most 
frequently reported; the decision will depend on the topic and 
nature of the review, noting that effect sizes often decrease 
over time. 
Analyses Select the effect size computed using the methodological 
approach considered to be most appropriate in the context of 
the review. For instance, select intention-to-treat-analyses if 
the intention is to estimate the effect of being assigned to an 
intervention rather than starting and adhering to the 
intervention. In the same vein, select partial correlation (or 
adjusted regression) coefficient if the aim is to estimate the 
strength of the association between two variables once a third 
variable is controlled for. 
Data sources (e.g. different, 
journal articles, conference 
abstracts, unpublished sources) 
Select the effect size from the most reliable or most recent 
source. For example, a Clinical Study Report from a randomized 
trial is typically less prone to reporting biases than a journal 
article about the same trial, and a journal article is usually 







Box 1. Example of an algorithm to select one result from each study in a review of the effects of 
Bacillus Calmette–Guérin (BCG) vaccine, diphtheria-tetanus-pertussis (DTP) vaccine and measles-
containing vaccine (MCV), to avoid multiplicity in the meta-analysis30  
 
1. Select comparison with vaccination sequence according to the World Health Organization 
(WHO) recommendations (e.g., BCG, then DTP, then MCV). We depict ‘DTP after BCG’ as 
‘BCP<DTP’. 
2. Select estimates from randomized comparisons in preference to observational 
comparisons. 
3. Select estimates adjusted for age and other vaccines in preference to those not adjusted 
for these. 
4. Estimates of primary interest 
– BCG 
A. BCG at birth vs. no BCG in preference to 
B. BCG vs. no BCG 
– DTP 
A. BCG<DTP (any number of doses) vs. BCG in preference to 
B. BCG<DTP (1 or 1-2 doses) vs. BCG in preference to 
C. BCG<DTP (2 or more doses) vs. BCG in preference to 
D. DTP (any number of doses) vs. no DTP in preference to 
E. DTP (1 or 1-2 doses) vs. no DTP in preference to 
F. DTP (2 or more doses) vs. no DTP 
– MCV 
A. BCG<DTP<MCV vs. BCG<DTP in preference to 
B. BCG<MCV vs. BCG in preference to 
C. DTP<MCV vs. DTP in preference to 
D. MCV vs. no MCV 
5. Select comparison with least co-administration of other vaccines, particularly when vs. 
unvaccinated children. 
6. Select comparison involving children from the same area in preference to a different area. 
7. Select estimate obtained using landmark rather than retrospective approach to analysis. 
8. Select estimate obtained from general population children rather than subgroups (e.g. 
hospitalized children). 
9. Select comparison including the most comprehensive adjustment for potential 
confounders. 
10. Select result for the shortest period of follow-up. 
11. Select result with the largest sample size. 
12. Select comparison with vaccination strategies according to the WHO recommendations 
(e.g. BCG at birth, MCV vaccine at 9 months) in preference to alternative strategies. 
13. Select estimate using the methodological approach claimed to be superior or more 
correct 








Figure 1. Multi-level (or hierarchical) structures of meta-analytic data sets. The data at the lowest 










Figure 2. Summary of steps of a systematic review in which multiplicity might need to be addressed. 
 
 
Figure 3. Suggested decision tree for dealing with multiplicity in any particular dimension. 
 
 
